A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia
A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia
The purpose of this study is to evaluate the efficacy and safety of KarXT in acutely psychotic Japanese adult participants with schizophrenia
Inclusion Criteria
Exclusion Criteria
Clinical.Trials@bms.com855-907-3286
Kōnan, Aichi-ken 4838248, Japan
+81587557251
MIdori-ku, Chiba-shi, Chiba 266-0007, Japan
Hadano-shi, Kanagawa 257-0003, Japan
Karatsu-shi, Saga-ken 847-0031, Japan
0955770711
Shimotsuga, Tochigi 321-0293, Japan
0282861111
0562971361
+81-562-93-2139
+81-47-372-3501
+81.43.291.1221
81-944-55-2000
81242275511
0572-54-8181
0823223111
+81-11-771-5660
81117067600
+81-463-58-0186
+81-42-778-8111
045-581-3055
81452615656
+81-45-843-8511
81-96-338-3838
81773622680
+81-986-22-0280
+8198-894-1301
072-847-3261
0669921001
0728223561
+81726931881
072-683-1221
0942827007
048-536-1366
81-28-673-2211
042-341-2711
042-795-2080
03-3762-4151
0333037211
0339391191
81836222111
+81-92-811-1821
+81-752515612
81985244181
+81-86-235-7242
048-857-6811
088-631-7130
073-441-0659
+81236312315